earnings

Biogen Profits Up in 2019 Despite Aducanumab Drama
Biogen Profits Up in 2019 Despite Aducanumab Drama
BioSpace
Biogen
earnings
aducanumab
Flag link:
Roche fights off biosimilar competition as new medicines' sales soar
Roche fights off biosimilar competition as new medicines' sales soar
Pharmaforum
Roche
biosimilars
earnings
Flag link:
Novartis Earnings Narrowly Top; Drug Giant Rises In Buy Zone
Novartis Earnings Narrowly Top; Drug Giant Rises In Buy Zone
Investors Business Daily
Novartis
earnings
Flag link:
Pfizer Misses Q4 Earnings Forecast as UpJohn, Lyrica Revenues Slide
Pfizer Misses Q4 Earnings Forecast as UpJohn, Lyrica Revenues Slide
TheStreet.com
Pfizer
earnings
Upjohn
Lyrica
Flag link:
3 Things You Can Count On With Illumina's Q4 Earnings Results
3 Things You Can Count On With Illumina's Q4 Earnings Results
Motley Fool
earnings
Illumina
Flag link:
Intuitive Surgical Grows Profits by 22% in the Fourth Quarter
Intuitive Surgical Grows Profits by 22% in the Fourth Quarter
Motley Fool
Intuitive Surgical
devices
earnings
Flag link:
J&J Drops in Device Sales for 2019 Earnings
J&J Drops in Device Sales for 2019 Earnings
Medical Devices and Diagnostics Industry
JNJ
earnings
devices
Flag link:
Abbott Laboratories Beats Revenue Expectations With Balanced Growth
Abbott Laboratories Beats Revenue Expectations With Balanced Growth
Motley Fool
Abbott Labs
earnings
devices
Flag link:
5 biopharmas to watch as the decade's last earnings kick off
5 biopharmas to watch as the decade's last earnings kick off
BioPharma Dive
earnings
Novartis
Biogen
Eli Lilly
Global Blood Therapeutics
Bluebird Bio
Flag link:
Will J&J (JNJ) Roll Out Pharma Q4 Earnings With a Beat?
Will J&J (JNJ) Roll Out Pharma Q4 Earnings With a Beat?
Yahoo/Zacks.com
JNJ
earnings
Flag link:
Abiomed Announces Preliminary Q3 Results, Slashes View Zacks
Abiomed Announces Preliminary Q3 Results, Slashes View Zacks
Yahoo/Zacks.com
Abiomed
earnings
devices
Flag link:
GW Pharmaceuticals' Preliminary Q4 Revenue of $108 Million Beats Expectations
GW Pharmaceuticals' Preliminary Q4 Revenue of $108 Million Beats Expectations
Motley Fool
GW Pharma
earnings
Flag link:
Portola's stock falls on weak Andexxa sales
Portola's stock falls on weak Andexxa sales
Marketwatch
Portola Pharmaceuticals
AndexXa
earnings
Flag link:
Clovis Oncology Reports Preliminary Fourth Quarter Sales of Rubraca and Sells Additional Shares
Clovis Oncology Reports Preliminary Fourth Quarter Sales of Rubraca and Sells Additional Shares
Motley Fool
Clovis Oncology
earnings
Flag link:
Vascepa sparkle set to light up Amarin's fourth quarter revenue
Vascepa sparkle set to light up Amarin's fourth quarter revenue
Endpoints
Amarin
Vascepa
earnings
Flag link:
Enanta Pharmaceuticals' Q4 Results Pulled Down by AbbVie's Sinking HCV Sales
Enanta Pharmaceuticals' Q4 Results Pulled Down by AbbVie's Sinking HCV Sales
Motley Fool
Enanta Pharmaceuticals
earnings
AbbVie
Mavyret
hepatitis C
Flag link:
AbbVie Shareholders Have a Lot to Look Forward To With Allergan
AbbVie Shareholders Have a Lot to Look Forward To With Allergan
Motley Fool
AbbVie
Allergan
earnings
M&A
Flag link:
AZ, Merck and Novartis top Big Pharma's Q3 growth charts. Teva and Pfizer? Not so much
AZ, Merck and Novartis top Big Pharma's Q3 growth charts. Teva and Pfizer? Not so much
Fierce Pharma
earnings
Big Pharma
AstraZeneca
Merck
Celgene
Novartis
Novo Nordisk
Pfizer
Flag link:
Merck KGaA posts higher profit and revenue as it lifts sales forecast
Merck KGaA posts higher profit and revenue as it lifts sales forecast
Marketwatch
Merck KGaA
earnings
Flag link:
5 Biotech Stocks Set to Beat Q3 Earnings Estimates
5 Biotech Stocks Set to Beat Q3 Earnings Estimates
Yahoo/Zacks.com
earnings
biotech
Eyenovia
SAGE Therapeutics
AC Immune
Ascendis
NGM Biopharmaceuticals
Flag link:

Pages